AP1976A - Disulfide, sulfide, sulfoxide and sulfone derivatives of cyclic sugars and uses thereof - Google Patents
Disulfide, sulfide, sulfoxide and sulfone derivatives of cyclic sugars and uses thereofInfo
- Publication number
- AP1976A AP1976A AP2006003605A AP2006003605A AP1976A AP 1976 A AP1976 A AP 1976A AP 2006003605 A AP2006003605 A AP 2006003605A AP 2006003605 A AP2006003605 A AP 2006003605A AP 1976 A AP1976 A AP 1976A
- Authority
- AP
- ARIPO
- Prior art keywords
- disulfide
- sulfoxide
- sulfide
- sulfone derivatives
- cyclic sugars
- Prior art date
Links
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 title 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 title 1
- 235000000346 sugar Nutrition 0.000 title 1
- -1 sulfone derivatives of cyclic sugars Chemical class 0.000 title 1
- 150000003462 sulfoxides Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200302368A ES2258365B1 (es) | 2003-10-03 | 2003-10-03 | Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos. |
| PCT/EP2004/010882 WO2005037842A1 (en) | 2003-10-03 | 2004-09-29 | Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP2006003605A0 AP2006003605A0 (en) | 2006-04-30 |
| AP1976A true AP1976A (en) | 2009-03-16 |
Family
ID=34451643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2006003605A AP1976A (en) | 2003-10-03 | 2004-09-29 | Disulfide, sulfide, sulfoxide and sulfone derivatives of cyclic sugars and uses thereof |
Country Status (34)
| Country | Link |
|---|---|
| US (3) | US7521571B2 (de) |
| EP (1) | EP1668017B1 (de) |
| JP (2) | JP4809769B2 (de) |
| KR (1) | KR101141683B1 (de) |
| CN (1) | CN1863805B (de) |
| AP (1) | AP1976A (de) |
| AR (1) | AR045962A1 (de) |
| AT (1) | ATE423781T1 (de) |
| AU (1) | AU2004281916B2 (de) |
| BR (1) | BRPI0415020A (de) |
| CA (1) | CA2540500C (de) |
| DE (2) | DE602004019666D1 (de) |
| DK (1) | DK1668017T3 (de) |
| EA (1) | EA008942B1 (de) |
| EC (1) | ECSP066542A (de) |
| ES (2) | ES2258365B1 (de) |
| GB (1) | GB2421241B (de) |
| GE (1) | GEP20084490B (de) |
| GT (1) | GT200400200A (de) |
| HR (1) | HRP20090152T3 (de) |
| IL (1) | IL174371A0 (de) |
| IS (1) | IS8436A (de) |
| MX (1) | MXPA06003610A (de) |
| NO (1) | NO20061872L (de) |
| NZ (1) | NZ546043A (de) |
| PA (1) | PA8614201A1 (de) |
| PE (1) | PE20050436A1 (de) |
| PL (1) | PL1668017T3 (de) |
| PT (1) | PT1668017E (de) |
| RS (1) | RS20060241A (de) |
| SI (1) | SI1668017T1 (de) |
| UY (1) | UY28547A1 (de) |
| WO (1) | WO2005037842A1 (de) |
| ZA (1) | ZA200603475B (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2258365B1 (es) * | 2003-10-03 | 2007-12-01 | Lacer, S.A. | Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos. |
| EP1941876A1 (de) * | 2006-12-28 | 2008-07-09 | Lacer, S.A. | Isosorbidmononitrit Derivate zur Behandlung von der Inflammation und okularen Hypertension |
| ES2332565B1 (es) * | 2007-01-23 | 2010-10-21 | Lacer, S.A. | Uso de derivados de mononitrato de dianhidrohexita como agentes antiinflamatorios. |
| CA2678325A1 (en) * | 2007-02-13 | 2008-08-21 | Cv Therapeutics, Inc. | Use of ranolazine for the treatment of non-coronary microvascular diseases |
| CA2678319A1 (en) * | 2007-02-13 | 2008-08-21 | Cv Therapeutics, Inc. | Use of ranolazine for the treatment of coronary microvascular diseases |
| US20090111826A1 (en) * | 2007-02-13 | 2009-04-30 | Louis Lange | Use of ranolazine for the treatment of cardiovascular diseases |
| CA2678515A1 (en) * | 2007-02-13 | 2008-08-21 | Cv Therapeutics, Inc. | Use of ranolazine for the treatment of cardiovascular diseases |
| WO2008116083A1 (en) * | 2007-03-22 | 2008-09-25 | Cv Therapeutics, Inc. | Use of ranolazine for elevated brain-type natriuretic peptide |
| CA2689633A1 (en) * | 2007-05-31 | 2008-12-11 | Cv Therapeutics, Inc. | Use of ranolazine for elevated brain-type natriuretic peptide |
| IE20070934A1 (en) | 2007-12-21 | 2009-06-24 | Trinity College Dublin | Efficient aspirin prodrugs |
| WO2009098113A1 (en) * | 2008-02-07 | 2009-08-13 | Nicox S.A. | Nitric oxide donor compounds |
| EP2149576A1 (de) * | 2008-07-22 | 2010-02-03 | Lacer, S.A. | Isosorbitnitrate mit vasodilatierender Wirksamkeit |
| EP2149577B1 (de) * | 2008-07-22 | 2011-04-27 | Lacer, S.A. | Neues stereospezifisches Verfahren zur Herstellung von Dioxabicyclooctan-Verbindungen |
| EP2177216A1 (de) * | 2008-10-13 | 2010-04-21 | Lacer, S.A. | Verwendung von Dianhydrohexit-Mononitrat-Derivaten als Heilungsmittel |
| WO2010055138A1 (en) * | 2008-11-14 | 2010-05-20 | Lacer, S.A. | New stereospecific method for the preparation of dioxa-bicyclooctane compounds |
| EP2199294A1 (de) | 2008-12-19 | 2010-06-23 | Lacer, S.A. | Neues stereoskopisches Verfahren zur Herstellung von Dioxa-Bicyclooctan-Nitratverbindungen |
| US20130131161A1 (en) * | 2009-12-23 | 2013-05-23 | Michael R. Bristow | Methods and compositions for cardiovascular diseases and conditions |
| FR2977252B1 (fr) * | 2011-06-30 | 2013-08-02 | Seppic Sa | Nouveaux esters de derives n-acyles d'acides amines et d'isosorbide, procede pour leur preparation, et utilisation en cosmetique et comme medicament. |
| JP6021938B2 (ja) | 2011-12-16 | 2016-11-09 | スリーエム イノベイティブ プロパティズ カンパニー | メルカプト含有ビスアンヒドロヘキシトール誘導体及びその使用 |
| KR20150123324A (ko) * | 2013-03-05 | 2015-11-03 | 아처 다니엘 미드랜드 캄파니 | 이소헥시드 모노트리플레이트 및 이의 합성 방법 |
| CN116173012A (zh) * | 2022-12-05 | 2023-05-30 | 温州医科大学 | 白当归脑在制备缺血性脑卒中神经保护用药物中的应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0290885A2 (de) * | 1987-05-08 | 1988-11-17 | CHIESI FARMACEUTICI S.p.A. | 1,4:3,6-Dianhydrosorbit-2-mononitrat- und -5-mononitratester, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen daraus |
| EP0530887A1 (de) * | 1991-08-07 | 1993-03-10 | Laboratoires Hoechst S.A. | Organische Nitrate, Verfahren zu deren Herstellung und ihre Verwendung in der Behandlung von kardiovaskulären Krankheiten |
| WO2000020420A1 (es) * | 1998-10-07 | 2000-04-13 | Lacer, S.A. | Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia disminuida |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU465217B2 (en) * | 1971-04-29 | 1975-09-18 | American Home Products Corporation | Mononitrte esters of 1,4:3, 6-dianhydro-d-glucitol |
| US3886186A (en) | 1971-04-29 | 1975-05-27 | American Home Prod | Mononitrate esters of 1,4:3,6-dianhydro-d-glucitol |
| DE3102947A1 (de) | 1981-01-29 | 1982-09-02 | Heinrich Mack Nachf., 7918 Illertissen | Verfahren zur herstellung von isosorbid-5-nitrat |
| US4891373A (en) * | 1988-11-23 | 1990-01-02 | Pfizer Inc. | Aminopropanol derivatives of 1,4:3,6-dianhydrohexitol nitrates, processes for their preparation and their use as medicaments |
| ES2125342T3 (es) * | 1992-07-30 | 1999-03-01 | Cal Int Ltd | Esteres y combinaciones de un nitrato organico y de un salicilato. |
| DE4410997A1 (de) * | 1994-03-30 | 1995-10-26 | Isis Pharma Gmbh | Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktionen |
| IL120531A (en) * | 1997-03-26 | 2006-12-31 | Yissum Res Dev Co | Nitric oxide donors and pharmaceutical compositions containing them |
| US20020013483A1 (en) * | 2000-07-13 | 2002-01-31 | Consortium Fur Elektrochemische Industrie Gmbh | Process for the preparation of dianhydrohexitol bisacylates |
| EP1337283A4 (de) * | 2000-10-27 | 2005-05-18 | Nitromed Inc | Verfahren zur behandlung von gefässerkrankungen, die durch stickoxidmangel gekennzeichnet sind |
| UA63467A (en) | 2003-04-22 | 2004-01-15 | Pharmaceutical composition of organic nitrates, dosage form based on pharmaceutical composition of organic nitrates and method of manufacture | |
| ES2258365B1 (es) * | 2003-10-03 | 2007-12-01 | Lacer, S.A. | Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos. |
-
2003
- 2003-10-03 ES ES200302368A patent/ES2258365B1/es not_active Expired - Fee Related
-
2004
- 2004-09-29 MX MXPA06003610A patent/MXPA06003610A/es active IP Right Grant
- 2004-09-29 HR HR20090152T patent/HRP20090152T3/xx unknown
- 2004-09-29 NZ NZ546043A patent/NZ546043A/en unknown
- 2004-09-29 DK DK04765682T patent/DK1668017T3/da active
- 2004-09-29 SI SI200431109T patent/SI1668017T1/sl unknown
- 2004-09-29 CN CN2004800289355A patent/CN1863805B/zh not_active Expired - Fee Related
- 2004-09-29 GE GEAP20049372A patent/GEP20084490B/en unknown
- 2004-09-29 PL PL04765682T patent/PL1668017T3/pl unknown
- 2004-09-29 EP EP04765682A patent/EP1668017B1/de not_active Expired - Lifetime
- 2004-09-29 US US10/544,237 patent/US7521571B2/en not_active Expired - Fee Related
- 2004-09-29 AP AP2006003605A patent/AP1976A/xx active
- 2004-09-29 AU AU2004281916A patent/AU2004281916B2/en not_active Ceased
- 2004-09-29 PT PT04765682T patent/PT1668017E/pt unknown
- 2004-09-29 RS YUP-2006/0241A patent/RS20060241A/sr unknown
- 2004-09-29 JP JP2006530042A patent/JP4809769B2/ja not_active Expired - Fee Related
- 2004-09-29 DE DE602004019666T patent/DE602004019666D1/de not_active Expired - Lifetime
- 2004-09-29 ES ES04765682T patent/ES2322468T3/es not_active Expired - Lifetime
- 2004-09-29 WO PCT/EP2004/010882 patent/WO2005037842A1/en not_active Ceased
- 2004-09-29 EA EA200600694A patent/EA008942B1/ru not_active IP Right Cessation
- 2004-09-29 BR BRPI0415020-1A patent/BRPI0415020A/pt not_active IP Right Cessation
- 2004-09-29 DE DE112004001860T patent/DE112004001860T5/de not_active Withdrawn
- 2004-09-29 AT AT04765682T patent/ATE423781T1/de not_active IP Right Cessation
- 2004-09-29 GB GB0605574A patent/GB2421241B/en not_active Expired - Fee Related
- 2004-09-29 CA CA2540500A patent/CA2540500C/en not_active Expired - Fee Related
- 2004-09-29 KR KR1020067006283A patent/KR101141683B1/ko not_active Expired - Fee Related
- 2004-09-30 PE PE2004000957A patent/PE20050436A1/es not_active Application Discontinuation
- 2004-10-01 AR ARP040103576A patent/AR045962A1/es unknown
- 2004-10-01 GT GT200400200A patent/GT200400200A/es unknown
- 2004-10-01 UY UY28547A patent/UY28547A1/es not_active Application Discontinuation
- 2004-10-01 PA PA20048614201A patent/PA8614201A1/es unknown
-
2006
- 2006-03-16 IL IL174371A patent/IL174371A0/en unknown
- 2006-04-27 NO NO20061872A patent/NO20061872L/no not_active Application Discontinuation
- 2006-05-02 ZA ZA200603475A patent/ZA200603475B/xx unknown
- 2006-05-03 IS IS8436A patent/IS8436A/is unknown
- 2006-05-03 EC EC2006006542A patent/ECSP066542A/es unknown
-
2009
- 2009-03-09 US US12/400,394 patent/US7777058B2/en not_active Expired - Fee Related
-
2010
- 2010-04-06 US US12/755,103 patent/US8541607B2/en not_active Expired - Fee Related
- 2010-10-08 JP JP2010228789A patent/JP2011012081A/ja active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0290885A2 (de) * | 1987-05-08 | 1988-11-17 | CHIESI FARMACEUTICI S.p.A. | 1,4:3,6-Dianhydrosorbit-2-mononitrat- und -5-mononitratester, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen daraus |
| EP0530887A1 (de) * | 1991-08-07 | 1993-03-10 | Laboratoires Hoechst S.A. | Organische Nitrate, Verfahren zu deren Herstellung und ihre Verwendung in der Behandlung von kardiovaskulären Krankheiten |
| WO2000020420A1 (es) * | 1998-10-07 | 2000-04-13 | Lacer, S.A. | Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia disminuida |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP1976A (en) | Disulfide, sulfide, sulfoxide and sulfone derivatives of cyclic sugars and uses thereof | |
| DK1919458T3 (da) | Syreresistent cysteamin, cystamin og derivater deraf | |
| DK1574452T3 (da) | Lukket kapsel med åbnemiddel | |
| ATE556593T1 (de) | Herbizide enthaltend substituierte thien-3-yl- sulfonylamino(thio)carbonyltriazolin(thi)one und flurtamone | |
| HUS1600006I1 (hu) | Helyettesített tien-3-il-szulfonilamino(tio)karboniltriazolin(ti)on-on és 4-HPPD inhibitorokon alapuló gyomirtó készítmények | |
| EP1953194A4 (de) | Polyarylen-sulfid-verbindung | |
| ATE407172T1 (de) | Schwefelpellet mit h2s-unterdrückungsmittel | |
| DE602004024386D1 (de) | Schwefelhaltige naphthoylimidderivate | |
| NO20053564D0 (no) | Bis(3)-alkoksyalkan-2-ol)sulfider, sulfoner og sulfoksider: nye overflateaktive midler. | |
| ATE354566T1 (de) | Aromatische sulfone und deren medizinische verwendung | |
| PL379466A1 (pl) | Heterocykliczne pochodne metylosulfonu | |
| IL185400A0 (en) | Synthesis of (e) -alpha, beta unsaturated sulfides, sulfones, sulfoxides and sulfonamides | |
| EP2046322A4 (de) | Aryl-vinyl-sulfide, -sulfone, -sulfoxide und -sulfonamide, derivate davon und therapeutische anwendungen davon | |
| IL168893A (en) | Sulfide-containing polythiols | |
| PL376646A1 (pl) | Prefabrykowany element budowlany | |
| IL179419A0 (en) | Heteroaryl sulfones and sulfonamides and therapeutic uses thereof | |
| ATE412645T1 (de) | Substituierte thiophene und deren verwendungen | |
| ITBO20050394A1 (it) | Pacchetto per il contenimento di articoli sfusi sbozzato per la realizzazione di tale pacchetto e metodo di piegatura di tale sbozzato | |
| ITMI20020772A0 (it) | Meccanismo per ante scorrevoli | |
| AP2022A (en) | Pesticidal treatment of stored foodstuffs, chambers, structures and works of art with sulphur compounds | |
| AU2003215665A1 (en) | Probucol derivatives | |
| GB0228870D0 (en) | Sulphur dioxide release coastings | |
| TW517772U (en) | Integral structure of auto-door with capable of overall open function | |
| TW551405U (en) | Pivot structure of air gates | |
| ATA17322002A (de) | Profilstab, insbesondere sparren- oder sprossenprofil |